跳至主要内容
临床试验/CTRI/2009/091/000551
CTRI/2009/091/000551已完成4 期

Evaluation of oxidative stress as a cause for idiopathic male infertility and the role of Addyzoa in its treatment

Dr Rajeev Kumar1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2009年3月15日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
50
试验地点
1
主要终点
Improvement in semen parameters

研究概览

简要总结

Addyzoa is a herbomineral product. It is promoted as a spermatogenic antioxidant that scavenges free radicals and reduces oxidative stress. This randomized, double blind, placebo controlled parallel group study aims to evaluate its benefits in men with idiopathic oligo/astheno/teratozoospermia.

研究设计

分配方式
Random Number Table
盲法
Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded

入排标准

入选标准

  • •Infertile male, normal semen volume with either oligospermia (sperm density between 5 and 20 million/mL) or asthenospermia or teratospermia by WHO criteria.

排除标准

  • •Identifiable cause for semen abnormality (varicocele, cryptorchidism, orchitis, radiation, chemotherapy, recent febrile illness, hormonal abnormality etc).

结局指标

主要结局

Improvement in semen parameters

时间窗: 3 months and 6 months

次要结局

  • Pregnancy(Upto 12 months)

研究者

发起方
Dr Rajeev Kumar

研究点 (1)

Loading locations...

相似试验